Hypothesis: Minimal changes in neural transmission in schizophrenia: Decreased glutamatergic and GABAergic functions in the prefrontal cortex

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 6, 2005, Pages 889-894

  Ohnuma, Tohru ^a,b   Suzuki, Toshihito ^a   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Juntendo University Hospital   (Japan)

Author keywords

GABA; Glutamate; Minimal change; mRNA; Pathophysiology; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; DOPAMINE RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IONOTROPIC RECEPTOR; MESSENGER RNA; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 5;

AUTOPSY; BRAIN FUNCTION; BRAIN LEVEL; BRAIN REGION; DISEASE MARKER; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEDICAL PARAMETERS; NEUROPATHOLOGY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN CHEMISTRY; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; MODELS, NEUROLOGICAL; PREFRONTAL CORTEX; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 23144456211     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.04.038     Document Type: Review

References (45)

1. S. Akbarian, J.J. Kim, S.G. Potkin, W.P. Hetrick, W.E. Bunney Jr., and E.G. Jones Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients Arch. Gen. Psychiatry 53 1996 425 436
2. S.E. Arnold, and J.Q. Trojanowski Recent advances in defining the neuropathology of schizophrenia Acta Neuropathol. 92 1996 217 231
3. S.E. Bachus, and J.E. Kleinman The neuropathology of schizophrenia J. Clin. Psychiatry 57 1996 72 83
4. F.M. Benes, R. Majocha, E.D. Bird, and C.A. Marotta Increased vertical axon numbers in cingulate cortex of schizophrenics Arch. Gen. Psychiatry 44 1987 1017 1021
5. F.M. Benes, I. Sorensen, S.L. Vincent, E.D. Bird, and M. Sathi Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain Cereb. Cortex 2 1992 503 512
6. B. Bogerts Recent advances in the neuropathology of schizophrenia Schizophr. Bull. 19 1993 431 445
7. B. Bogerts, P. Falkai, B. Greve, T. Schneider, and U. Pfeiffer The neuropathology of schizophrenia: past and present J. Hirnforsch. 34 1993 193 205
8. D.A. Daly, and B. Moghaddam Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats Neurosci. Lett. 152 1993 61 64
9. J.F. Deakin, P. Slater, M.D. Simpson, A.C. Gilchrist, W.J. Skan, M.C. Royston, G.P. Reynolds, and A.J. Cross Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia J. Neurochem. 52 1989 1781 1786
10. I. Divac, F. Fonnum, and J. Storm-Mathisen High affinity uptake of glutamate in terminals of corticostriatal axons Nature 266 1977 377 378
11. E.F. Domino Abnormal mental states induced by phencyclidine as a model of schizophrenia E.F. Domino E.D. Luby PCP (Phencyclidine): Historical and Current Perspectives 1981 NPP Books Michigan 401 418
12. S. Dracheva, S.A. Marras, S.L. Elhakem, F.R. Kramer, K.L. Davis, and V. Haroutunian N-methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia Am. J. Psychiatry 158 2001 1400 1410
13. O.V. Godukhin, A.D. Zharikova, and V.I. Novoselov The release of labeled l-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex Neuroscience 5 1980 2151 2154
14. P.J. Harrison Advances in post mortem molecular neurochemistry and neuropathology: examples from schizophrenia research Br. Med. Bull. 52 1996 527 538
15. D.J. Healy, V. Haroutunian, P. Powchik, M. Davidson, K.L. Davis, S.J. Watson, and J.H. Meador-Woodruff AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics Neuropsychopharmacology 19 1998 278 286
16. M. Ishimaru, A. Kurumaji, and M. Toru NMDA-associated glycine binding site increases in schizophrenic brains Biol. Psychiatry 32 1992 379 381
17. M. Ishimaru, A. Kurumaji, and M. Toru Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis Biol. Psychiatry 35 1994 84 95
18. J.S. Kim, R. Hasller, P. Hau, and K.S. Paik Effect of frontal cortex ablation on striatal glutamic acid level in rat Brain Res. 132 1977 370 374
19. A.E. Kingsbury, O.J. Foster, A.P. Nisbet, N. Cairns, L. Bray, D.J. Eve, A.J. Lees, and C.D. Marsden Tissue pH as an indicator of mRNA preservation in human post-mortem brain Brain Res. Mol. Brain Res. 28 1995 311 318
20. 3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients J. Neural Transm. 77 1989 231 236
21. M.O. Krebs Glutamatergic hypothesis of schizophrenia: psychoses induced by phencyclidine and cortical-subcortical imbalance Encephale 21 1995 581 588
22. 3H]amino-3- hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics J. Neurochem. 59 1992 829 837
23. R. Labarca, H. Silva, S. Jerez, A. Ruiz, P. Renterias, C. Ogalde, and G. Bustos Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients Schizophr. Res. 16 1995 83 85
24. T. Lee, and P. Seeman Elevation of brain neuroleptic/dopamine receptors in schizophrenia Am. J. Psychiatry 137 1980 191 197
25. 3H-apomorphine in schizophrenic brains Nature 274 1978 897 900
26. G.L. Miklos, and R. Maleszka Microarray reality checks in the context of a complex disease Nat. Biotechnol. 22 2004 615 621
27. 3H]kainic acid binding in the prefrontal cortex in schizophrenia Neurosci. Lett. 40 1983 245 250
28. T. Ohnuma, S.J. Augood, H. Arai, P.J. McKenna, and P.C. Emson Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia Brain Res. Mol. Brain Res. 56 1998 207 217
29. T. Ohnuma, S.J. Augood, H. Arai, P.J. McKenna, and P.C. Emson Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression Neuroscience 93 1999 441 448
30. T. Ohnuma, H. Kato, H. Arai, R.L. Faull, P.J. McKenna, and P.C. Emson Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia NeuroReport 11 2000 3133 3137
31. T. Ohnuma, H. Kato, H. Arai, P.J. McKenna, and P.C. Emson Expression of Fyn, a non-receptor tyrosine kinase in prefrontal cortex from patients with schizophrenia and its correlation with clinical onset Brain Res. Mol. Brain Res. 112 2003 90 94
32. Y. Okubo, T. Suhara, K. Suzuki, K. Kobayashi, O. Inoue, O. Terasaki, Y. Someya, T. Sassa, Y. Sudo, E. Matsushima, M. Iyo, Y. Tateno, and M. Toru Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET Nature 385 1997 634 636
33. J.W. Olney, and N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch. Gen. Psychiatry 52 1995 998 1007
34. F. Owen, A.J. Cross, T.J. Crow, A. Longden, M. Poulter, and G.J. Riley Increased dopamine-receptor sensitivity in schizophrenia Lancet 2 1978 223 226
35. R.G. Paulman, M.D. Devous Sr., R.R. Gregory, J.H. Herman, L. Jennings, F.J. Bonte, H.A. Nasrallah, and J.D. Raese Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function Biol. Psychiatry 27 1990 377 399
36. D. Senitz, and E. Winkelmann Neuronal structure abnormality in the orbito-frontal cortex of schizophrenics J. Hirnforsch. 32 1991 149 158
37. A.D. Sherman, T.S. Hegwood, S. Baruah, and R. Waziri Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics Biol. Psychiatry 30 1991 1191 1198
38. M.D. Simpson, P. Slater, M.C. Royston, and J.F. Deakin Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication Schizophr. Res. 6 1991 41 48
39. B.P. Sokolov Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics J. Neurochem. 71 1998 2454 2464
40. T. Storck, S. Schulte, K. Hofmann, and W. Stoffel Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain Proc. Natl. Acad. Sci. U. S. A. 89 1992 10955 10959
41. A.M. Thierry, J.P. Tassin, G. Blanc, and J. Glowinski Selective activation of mesocortical DA system by stress Nature 263 1976 242 244
42. M. Toru, S. Watanabe, H. Shibuya, T. Nishikawa, K. Noda, H. Mitsushio, H. Ichikawa, A. Kurumaji, M. Takashima, N. Mataga, and A. Ogawa Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients Acta Psychiatr. Scand. 78 1988 121 137
43. D.R. Weinberger, and K.F. Berman Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia Schizophr. Bull. 14 1988 157 168
44. D.R. Weinberger, K.F. Berman, and R.F. Zec Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence Arch. Gen. Psychiatry 43 1986 114 124
45. B.K. Yamamoto, and M.A. Cooperman Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations J. Neurosci. 14 1994 4159 4166